FDA Inspection 1002458 — Stallergenes
The FDA completed an inspection of Stallergenes on Jul 5, 2016 in Antony. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 5, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Antony (France)